T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Saturday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Trading Down 22.1 %

Shares of NASDAQ:TTOO opened at $0.18 on Friday. The business’s fifty day moving average price is $0.28 and its two-hundred day moving average price is $1.30. T2 Biosystems has a fifty-two week low of $0.06 and a fifty-two week high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.